This $469,381 Project Grant award from the Department of the Army Medical Command under the Military Medical Research and Development (CFDA 12.420) program supports research to engineer cytotoxic lymphocytes that can infiltrate ovarian cancer tumors using metabolite-sensing receptors. The award to The Leland Stanford Junior University covers a period from April 15, 2025 to April 14, 2027. The research aims to transform healthcare for military service members and the public through innovative, impactful biomedical investigations spanning basic, applied, and translational domains. The Military Medical Research and Development program frequently funds advanced research at prominent academic medical centers and research institutions to address a wide range of health conditions relevant to military personnel and veterans.
Mod # | Description | Reason For Modification | Federal Obligation (Click to sort descending) | Date (Click to sort ascending) |
|---|---|---|---|---|
| Not listed | $469.4k | 4/7/25 |